BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34492551)

  • 1. Cathepsin C inhibitors as anti-inflammatory drug discovery: Challenges and opportunities.
    Shen XB; Chen X; Zhang ZY; Wu FF; Liu XH
    Eur J Med Chem; 2021 Dec; 225():113818. PubMed ID: 34492551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and
    Chen X; Yan Y; Zhang Z; Zhang F; Liu M; Du L; Zhang H; Shen X; Zhao D; Shi JB; Liu X
    J Med Chem; 2021 Aug; 64(16):11857-11885. PubMed ID: 34374541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillon-Lefèvre syndrome: correlating the molecular, cellular, and clinical consequences of cathepsin C/dipeptidyl peptidase I deficiency in humans.
    Pham CT; Ivanovich JL; Raptis SZ; Zehnbauer B; Ley TJ
    J Immunol; 2004 Dec; 173(12):7277-81. PubMed ID: 15585850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo inhibition of serine protease processing requires a high fractional inhibition of cathepsin C.
    Méthot N; Guay D; Rubin J; Ethier D; Ortega K; Wong S; Normandin D; Beaulieu C; Reddy TJ; Riendeau D; Percival MD
    Mol Pharmacol; 2008 Jun; 73(6):1857-65. PubMed ID: 18326050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung Protection by Cathepsin C Inhibition: A New Hope for COVID-19 and ARDS?
    Korkmaz B; Lesner A; Marchand-Adam S; Moss C; Jenne DE
    J Med Chem; 2020 Nov; 63(22):13258-13265. PubMed ID: 32692176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases.
    Guarino C; Hamon Y; Croix C; Lamort AS; Dallet-Choisy S; Marchand-Adam S; Lesner A; Baranek T; Viaud-Massuard MC; Lauritzen C; Pedersen J; Heuzé-Vourc'h N; Si-Tahar M; Fıratlı E; Jenne DE; Gauthier F; Horwitz MS; Borregaard N; Korkmaz B
    Biochem Pharmacol; 2017 May; 131():52-67. PubMed ID: 28193451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin C role in inflammatory gastroenterological, renal, rheumatic, and pulmonary disorders.
    Aghdassi AA; Pham C; Zierke L; Mariaule V; Korkmaz B; Rhimi M
    Biochimie; 2024 Jan; 216():175-180. PubMed ID: 37758158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss-of-function mutations in cathepsin C in two families with Papillon-Lefèvre syndrome are associated with deficiency of serine proteinases in PMNs.
    de Haar SF; Jansen DC; Schoenmaker T; De Vree H; Everts V; Beertsen W
    Hum Mutat; 2004 May; 23(5):524. PubMed ID: 15108292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic targeting of cathepsin C: from pathophysiology to treatment.
    Korkmaz B; Caughey GH; Chapple I; Gauthier F; Hirschfeld J; Jenne DE; Kettritz R; Lalmanach G; Lamort AS; Lauritzen C; Łȩgowska M; Lesner A; Marchand-Adam S; McKaig SJ; Moss C; Pedersen J; Roberts H; Schreiber A; Seren S; Thakker NS
    Pharmacol Ther; 2018 Oct; 190():202-236. PubMed ID: 29842917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare CTSC mutation in Papillon-Lefèvre Syndrome results in abolished serine protease activity and reduced NET formation but otherwise normal neutrophil function.
    Sanchez Klose FP; Björnsdottir H; Dahlstrand Rudin A; Persson T; Khamzeh A; Sundqvist M; Thorbert-Mros S; Dieckmann R; Christenson K; Bylund J
    PLoS One; 2021; 16(12):e0261724. PubMed ID: 34932608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic utility and medicinal chemistry of cathepsin C inhibitors.
    Guay D; Beaulieu C; Percival MD
    Curr Top Med Chem; 2010; 10(7):708-16. PubMed ID: 20337582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haim Munk syndrome and Papillon Lefevre syndrome--allelic mutations in cathepsin C with variation in phenotype.
    Rai R; Thiagarajan S; Mohandas S; Natarajan K; Shanmuga Sekar C; Ramalingam S
    Int J Dermatol; 2010 May; 49(5):541-3. PubMed ID: 20534088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paths of glorious proteases.
    Nuckolls GH; Slavkin HC
    Nat Genet; 1999 Dec; 23(4):378-80. PubMed ID: 10581013
    [No Abstract]   [Full Text] [Related]  

  • 14. Cathepsin C inhibition as a potential treatment strategy in cancer.
    Korkmaz B; Lamort AS; Domain R; Beauvillain C; Gieldon A; Yildirim AÖ; Stathopoulos GT; Rhimi M; Jenne DE; Kettritz R
    Biochem Pharmacol; 2021 Dec; 194():114803. PubMed ID: 34678221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A family with Papillon-Lefevre syndrome reveals a requirement for cathepsin C in granzyme B activation and NK cell cytolytic activity.
    Meade JL; de Wynter EA; Brett P; Sharif SM; Woods CG; Markham AF; Cook GP
    Blood; 2006 May; 107(9):3665-8. PubMed ID: 16410452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel point mutations, deletions, and polymorphisms in the cathepsin C gene in nine families from Europe and North Africa with Papillon-Lefèvre syndrome.
    Lefèvre C; Blanchet-Bardon C; Jobard F; Bouadjar B; Stalder JF; Cure S; Hoffmann A; Prud'Homme JF; Fischer J
    J Invest Dermatol; 2001 Dec; 117(6):1657-61. PubMed ID: 11886537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papillon-Lefèvre syndrome patient reveals species-dependent requirements for neutrophil defenses.
    Sørensen OE; Clemmensen SN; Dahl SL; Østergaard O; Heegaard NH; Glenthøj A; Nielsen FC; Borregaard N
    J Clin Invest; 2014 Oct; 124(10):4539-48. PubMed ID: 25244098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Terminal Nonsense Mutation of the Cathepsin C Gene in a Patient With Atypical Papillon-Lefèvre Syndrome.
    Moura AL; Regateiro FS; Peres Resende E; Coimbra Silva H; Gonçalo M; Todo Bom A; Faria E
    J Investig Allergol Clin Immunol; 2020 Apr; 30(2):151-153. PubMed ID: 31751289
    [No Abstract]   [Full Text] [Related]  

  • 19. NSP4 is stored in azurophil granules and released by activated neutrophils as active endoprotease with restricted specificity.
    Perera NC; Wiesmüller KH; Larsen MT; Schacher B; Eickholz P; Borregaard N; Jenne DE
    J Immunol; 2013 Sep; 191(5):2700-7. PubMed ID: 23904161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagic dysfunction in patients with Papillon-Lefèvre syndrome is restored by recombinant cathepsin C treatment.
    Bullón P; Castejón-Vega B; Román-Malo L; Jimenez-Guerrero MP; Cotán D; Forbes-Hernandez TY; Varela-López A; Pérez-Pulido AJ; Giampieri F; Quiles JL; Battino M; Sánchez-Alcázar JA; Cordero MD
    J Allergy Clin Immunol; 2018 Oct; 142(4):1131-1143.e7. PubMed ID: 29410039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.